The roles of the Na+/K+-ATPase, NKCC, and K+ channels in regulating local sweating and cutaneous blood flow during exercise in humans in vivo

Physiol Rep. 2016 Nov;4(22):e13024. doi: 10.14814/phy2.13024.

Abstract

Na+/K+-ATPase has been shown to regulate the sweating and cutaneous vascular responses during exercise; however, similar studies have not been conducted to assess the roles of the Na-K-2Cl co-transporter (NKCC) and K+ channels. Additionally, it remains to be determined if these mechanisms underpinning the heat loss responses differ with exercise intensity. Eleven young (24 ± 4 years) males performed three 30-min semirecumbent cycling bouts at low (30% VO2peak), moderate (50% VO2peak), and high (70% VO2peak) intensity, respectively, each separated by 20-min recovery periods. Using intradermal microdialysis, four forearm skin sites were continuously perfused with either: (1) lactated Ringer solution (Control); (2) 6 mmol·L-1 ouabain (Na+/K+-ATPase inhibitor); (3) 10 mmol·L-1 bumetanide (NKCC inhibitor); or (4) 50 mmol·L-1 BaCl2 (nonspecific K+ channel inhibitor); sites at which we assessed local sweat rate (LSR) and cutaneous vascular conductance (CVC). Inhibition of Na+/K+-ATPase attenuated LSR compared to Control during the moderate and high-intensity exercise bouts (both P ˂ 0.01), whereas attenuations with NKCC and K+ channel inhibition were only apparent during the high-intensity exercise bout (both P ≤ 0.05). Na+/K+-ATPase inhibition augmented CVC during all exercise intensities (all P ˂ 0.01), whereas CVC was greater with NKCC inhibition during the low-intensity exercise only (P ˂ 0.01) and attenuated with K+ channel inhibition during the moderate and high-intensity exercise conditions (both P ˂ 0.01). We show that Na+/K+-ATPase, NKCC and K+ channels all contribute to the regulation of sweating and cutaneous blood flow but their influence is dependent on the intensity of dynamic exercise.

Keywords: NKCC; Exercise; K+ channels; Na+/K+‐ATPase; heat loss; microcirculation; sweat gland.

MeSH terms

  • Adult
  • Barium Compounds / administration & dosage
  • Barium Compounds / pharmacology
  • Body Temperature Regulation
  • Bumetanide / administration & dosage
  • Bumetanide / pharmacology
  • Chlorides / administration & dosage
  • Chlorides / pharmacology
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacology
  • Exercise / physiology*
  • Humans
  • Injections, Intradermal / methods
  • Male
  • Ouabain / administration & dosage
  • Ouabain / pharmacology
  • Potassium Channels / metabolism
  • Potassium Channels / physiology*
  • Regional Blood Flow / drug effects*
  • Regional Blood Flow / physiology
  • Skin / blood supply*
  • Skin / drug effects
  • Skin / innervation
  • Skin Physiological Phenomena / drug effects
  • Sodium Potassium Chloride Symporter Inhibitors / administration & dosage
  • Sodium Potassium Chloride Symporter Inhibitors / pharmacology
  • Sodium-Potassium-Chloride Symporters / metabolism
  • Sodium-Potassium-Chloride Symporters / physiology*
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Sodium-Potassium-Exchanging ATPase / physiology*
  • Sweat Glands / drug effects
  • Sweating / drug effects*
  • Sweating / physiology
  • Vasodilation / physiology
  • Young Adult

Substances

  • Barium Compounds
  • Chlorides
  • Enzyme Inhibitors
  • Potassium Channels
  • Sodium Potassium Chloride Symporter Inhibitors
  • Sodium-Potassium-Chloride Symporters
  • barium chloride
  • Bumetanide
  • Ouabain
  • Sodium-Potassium-Exchanging ATPase